Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sheila Xinxuan Soh
Observed names:
Sheila Soh,
Sheila X Soh,
Sheila X. Soh,
Sheila X.X. Soh
Institution:
National University Hospital
Observed institutions:
National University of Singapore,
Duke-NUS Medical School,
National University Hospital,
National University Health System
ORCID:
0000-0003-2497-7046
Observed ORCID:
0000-0003-2497-7046
OpenAlex ID:
A5000754700
A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer
2012
·
King Pan Ng
, Axel M Hillmer
, et al.
·
Nature Medicine
·
556
An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemia
2020
·
Tun Kiat Ko
, Asif Javed
, et al.
·
Blood
·
72
A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lung cancer
2017
·
Sheila X. Soh
, Fahad J. Siddiqui
, et al.
·
Oncotarget
·
17
PDF
Multi-Agent Chemotherapy Overcomes Glucocorticoid Resistance Conferred by a BIM Deletion Polymorphism in Pediatric Acute Lymphoblastic Leukemia
2014
·
Sheila Xinxuan Soh
, Joshua Yew Suang Lim
, et al.
·
PLoS ONE
·
11
PDF
Methods to reduce lipemic interference in clinical chemistry tests: a systematic review and recommendations
2021
·
Sheila X. Soh
, Tze Ping Loh
, et al.
·
Clinical Chemistry and Laboratory Medicine (CCLM)
·
9
A novel BIM deletion polymorphism: implications and lessons for cancer targeted therapies.
2013
·
Sheila Soh
, S Tiong Ong
·
PubMed
·
6
A comparison of fetal hemoglobin interference in routine high-performance liquid chromatography, immunoassay, and enzymatic methods of glycated hemoglobin measurement
2025
·
Sheila X Soh
, Tze Ping Loh
, et al.
·
Laboratory Medicine
·
2
A curious case of a negative control line on a dengue duo assay due to interference – A case report
2024
·
Sheila X. Soh
, Tze Ping Loh
, et al.
·
Annals of Clinical Biochemistry International Journal of Laboratory Medicine
·
1
Multi-Agent Chemotherapy Overcomes Steroid Resistance Conferred by a BIM Deletion Polymorphism in Pediatric Acute Lymphoblastic Leukemia (ALL)
2013
·
Sheila X.X. Soh
, Joshua Y.S. Lim
, et al.
·
Blood
A novel BIM deletion polymorphism : implications and lessons for cancer targeted therapies (第75回日本血液学会学術集会 教育講演特集号) -- (骨髄系腫瘍 : CML/MPN/MDS)
2013
·
Sheila Soh
, S. Tiong Ong
·
臨床血液
Abstract 1911: A common BIM polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer
2012
·
S. Tiong Ong
, King Pan Ng
, et al.
·
Cancer Research
Show more works
View as search
Works count:
11
Citation count:
674
H-index:
6
I10-index:
4
Year
Topic
Type
